Integrative Cancer Therapies (Feb 2024)

Baduanjin Mind-Body Exercise for Cancer-Related Fatigue: Protocol for a Remotely Delivered Randomized Wait-List Controlled Feasibility Study

  • Sean Walsh PhD,
  • Kang Wang PhD,
  • Anderson Lam BTCM,
  • Shihao Du PhD,
  • Yanbin Hu PhD,
  • Yu-Ting Sun PhD,
  • Elise Tcharkhedian BPhysio (Honours),
  • Evangeline Nikas BAppSc(PhysTher),
  • Gregory Webb DipAppSci,
  • Eugene Moylan MBBS, FRACP,
  • Stephen Della-Fiorentina MBBS, FRACP,
  • Paul Fahey PhD,
  • Xin Shelley Wang MD, MPH,
  • Ming Chen PhD,
  • Xiaoshu Zhu PhD

DOI
https://doi.org/10.1177/15347354231226127
Journal volume & issue
Vol. 23

Abstract

Read online

Background: People living with a cancer diagnosis often experience cancer-related fatigue (CRF). Between 9% and 45% of people report CRF as moderate to severe, negatively impacting their quality-of-life (QOL). The evidence-base for managing CRF recommends exercise-related therapies over pharmaceutical interventions. One such exercise-like therapy is Baduanjin mind-body exercise (MBE), which has additional benefits. A remotely delivered program may further benefit people with CRF. The primary objective of this pilot will test study feasibility of a remotely delivered Baduanjin MBE exercise program for people living with CRF. Methods: This is a randomized wait-list controlled pilot study and will take place in Sydney, Australia. Subject to informed consent, 40 adults with moderate CRF levels and receiving or previously received adjuvant chemotherapy, will undertake a home-based 8-week Baduanjin MBE program supported by online resources and instructors. The primary feasibility outcomes are recruitment, enrollment, retention, and adherence rates; and safety as measured by tolerance and adverse-event frequency. Clinical outcomes (eg, changes in CRF, QOL, and participant perceptions) are assessed at pre-intervention, week 1, week 4, week 8, and post-intervention. Analyses follows the Intent-to-Treat (all participants as per randomization) and per-protocol (participants adhering to the protocol). Missing data will be imputed from previous data entries and regression models may be tested to predict missing outcomes. Discussion: To our knowledge, this is the first study evaluating the feasibility and effects of Baduanjin MBE on CRF using a remote delivery method. These feasibility data will inform a fully powered future trial investigating evidence of effect on CRF and QOL. Trial registration : Australian and New Zealand Clinical Trials Registry (ANZCTR 12623000177651). Ringgold ID : 651498 Chinese Medicine Centre